+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Economic Benefit-Cost Analysis of Select Secondary Prevention Interventions in LMIC



Economic Benefit-Cost Analysis of Select Secondary Prevention Interventions in LMIC



Global Heart 10(4): 319-321



We present a quantitative economic benefit-cost analysis of 2 secondary prevention targets that are part of the World Health Organization's Global Monitoring Framework for noncommunicable diseases (NCD). These targets are expected to contribute to the achievement of the overall NCD target proposed for the Post-2015 Sustainable Development Goal Framework. We estimate that interventions would need to avert roughly 6 million to 7 million NCD deaths worldwide in 2030 to meet the target. We calculate that the combination of tobacco taxation that achieves 50% reduction in use and 70% coverage of high-risk populations with a multidrug regimen can provide one-half of that mortality reduction in 2030, at a benefit-cost ratio of 7:1, or U.S. $7 in benefits for each U.S. $1 in cost.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057685155

Download citation: RISBibTeXText

PMID: 26704964

DOI: 10.1016/j.gheart.2015.09.002


Related references

Universal family-focused interventions in alcohol-use disorder prevention: Cost-effectiveness and cost-benefit analyses of two interventions. Journal of Studies on Alcohol 63(2): 219-228, 2002

A cost-benefit analysis of three older adult fall prevention interventions. Journal of Safety Research 52: 65-70, 2015

Secondary Analysis of Economic Data: A Review of Cost-Benefit Studies of Neonatal Screening for Phenylketonuria. Journal of Epidemiology and Community Health (1979-) 53(3): 179-186, 1999

Secondary analysis of economic data: a review of cost-benefit studies of neonatal screening for phenylketonuria. Journal of Epidemiology and Community Health 53(3): 179-186, 1999

Cost-benefit analysis of an evidence-based secondary prevention of coronary heart diseases by statins. An analysis for Germany from a social security perspective. Medizinische Klinik 95(6): 305-313, 2000

Economic evaluation of prevention programmes for occupational health and safety: the pertinence of cost-benefit analysis. Sante Publique 22(1): 23-35, 2010

Benefit-cost analysis: a select bibliography. Exchange Bibliography. Council of Planning Librarians. Monticello, Ill, 267, 44, 1972

The productivity assessment tool: computer-based cost benefit analysis model for the economic assessment of occupational health and safety interventions in the workplace. Journal of Safety Research 36(3): 209-214, 2005

Cost-benefit analysis indicates the positive economic benefits of the Expanded Food and Nutrition Education Program related to chronic disease prevention. Journal of Nutrition Education and Behavior 34(1): 26-37, 2002

Economic analysis and public health: Why do we need economic evaluation applied to diabetes? What methods must we choose: Cost-effectiveness, cost-utility, cost-benefit? Are such studies useful in terms of public health?. Diabete and Metabolisme 19(5 Suppl. ): 473-476, 1993

Economic analysis and public health. Why does one need economic evaluation applied to diabetes? What methods does one choose: cost effectiveness, cost utility, cost benefit? Are such studies useful in terms of public health?. Diabete and Metabolisme 19(5 Suppl): 473-476, 1993

Primary Prevention in LMIC: From Population-Based Surveys to Risk Factor Interventions. Global Heart 12(3): 177-178, 2017

Multiple Risk Factor Interventions for Primary Prevention of CVD in LMIC: A Cochrane Review. Global Heart 12(3): 199-208.E8, 2017

Secondary Prevention of CVD in LMIC: Care for the Growing Affected Population. Global Heart 12(4): 271-272, 2017

Patient expectations of benefit from common interventions for low back pain and effects on outcome: secondary analysis of a clinical trial of manual therapy interventions. Journal of Manual and Manipulative Therapy 19(1): 20-25, 2011